PulseExploreJournal ClubResearchersJournals
Instagram
HomeJournal ClubExplore
Synapse
⌘+K
Synapse
September 10, 2025Cardiology in Review

Anticoagulation in Atrial Fibrillation and Dementia

View Full Paper
Ask AI
Bookmark
Share

Authors

JRJonah RocheeldJKJosef KusayevWFWilliam H. Frishman

Discussion

Loading...

Member takes

Overview

Narrative review highlights anticoagulant use in patients with atrial fibrillation and dementia, suggesting cautious application in advanced cases.

Key Points

  • Anticoagulation shows a net mortality benefit in patients with early-stage dementia and atrial fibrillation.
  • Larger cohort studies suggest anticoagulants reduce thromboembolic events, but advanced dementia presents mixed outcomes.
  • Use of direct oral anticoagulants may lower risks associated with severe bleeding compared to warfarin.
  • Current literature lacks randomized controlled trials specifically targeting dementia subgroups, indicating a research gap.

Cite This Study

Rocheeld et al. (2025) studied this question.

synapsesocial.com/papers/68c23e02b210217d64790300https://doi.org/10.1097/crd.0000000000001011
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparison of Safety and Effectiveness Between Direct Oral Anticoagulants and Vitamin K Antagonists in Dementia Patients with Atrial Fibrillation: A Systematic Review and Meta-Analysis.2025 · 1 citations
  2. 2Consider frailty status and comorbidities when choosing anticoagulant treatment for older patients with atrial fibrillation2026
  3. 3Atrial Fibrillation as a Driver of Cognitive Decline2026
  4. 4Clinical Outcomes of Oral Anticoagulation in Elderly East Asian Patients with Atrial Fibrillation: A Retrospective Single-Center Study2025
  5. 5How can we reduce thrombotic and hemorrhagic events in elderly patients with atrial fibrillation?2025 · 3 citations